{"id":"insulin-infusion","safety":{"commonSideEffects":[{"rate":"variable, depends on dosing and monitoring","effect":"Hypoglycemia"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Lipodystrophy"},{"rate":null,"effect":"Weight gain"}]},"_chembl":{"chemblId":"CHEMBL1201631","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Insulin infusion is a therapeutic delivery method for insulin, a hormone that binds to insulin receptors on cells to facilitate glucose uptake from the blood and promote glycogen synthesis and storage. This approach is used in acute care settings or for patients requiring continuous insulin delivery to maintain tight glycemic control. The infused insulin mimics the body's natural insulin secretion pattern to normalize blood glucose levels.","oneSentence":"Insulin infusion delivers exogenous insulin directly into the bloodstream to regulate blood glucose by promoting cellular glucose uptake and storage.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:49:11.496Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus (when oral agents are insufficient)"},{"name":"Acute hyperglycemia in hospitalized patients"},{"name":"Diabetic ketoacidosis"}]},"trialDetails":[{"nctId":"NCT02230137","phase":"NA","title":"Text Message for Adolescents With Poorly Controlled Type 1 Diabetes","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-02","conditions":"Type 1 Diabetes","enrollment":92},{"nctId":"NCT07494084","phase":"PHASE4","title":"Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance","status":"NOT_YET_RECRUITING","sponsor":"Washington State University","startDate":"2026-05-01","conditions":"Shift Work Schedule, Circadian Rhythm, Insulin Resistance","enrollment":24},{"nctId":"NCT07490964","phase":"","title":"Polycystic Ovary Syndrome in Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2026-04-01","conditions":"Type 1 Diabetes Mellitus, Polycystic Ovary Syndrome (PCOS)","enrollment":60},{"nctId":"NCT06739811","phase":"NA","title":"Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)","status":"RECRUITING","sponsor":"Medtronic Diabetes","startDate":"2025-03-21","conditions":"Type I Diabetes","enrollment":40},{"nctId":"NCT04542148","phase":"PHASE2","title":"Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2022-02-10","conditions":"Diabetes Mellitus, Type 2, Preterm Birth, Pregnancy, High Risk","enrollment":120},{"nctId":"NCT07485101","phase":"NA","title":"Glycemic Targets During CPB in Elderly Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2026-04-01","conditions":"Glycemic Management During CPB in Elderly Diabetic Cardiac Surgery","enrollment":3000},{"nctId":"NCT06198725","phase":"NA","title":"Intervention for Children With Type 1 Diabetes Targeting Gut Microbes","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2024-01-08","conditions":"Type 1 Diabetes","enrollment":110},{"nctId":"NCT07466173","phase":"NA","title":"The Importance of Insulin Action in the Brain for the Immune System During Physical Activity-Overweight","status":"NOT_YET_RECRUITING","sponsor":"University of Ulm","startDate":"2026-04","conditions":"Insulin Sensitivity","enrollment":8},{"nctId":"NCT06686329","phase":"NA","title":"Physical Activity to Prevent and Treat Hyperglycemia From a Mistimed Bolus Insulin Dose","status":"RECRUITING","sponsor":"Jane Yardley","startDate":"2025-03-17","conditions":"Type 1 Diabetes Mellitus","enrollment":30},{"nctId":"NCT06872333","phase":"PHASE2","title":"Allo HSCT for High Risk Hemoglobinopathies","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-11-19","conditions":"Graft Failure, Sickle Cell Disease, Hemoglobinopathies","enrollment":62},{"nctId":"NCT00690066","phase":"PHASE2","title":"PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-06-11","conditions":"Type 1 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Insulin-Dependent","enrollment":63},{"nctId":"NCT04722354","phase":"PHASE2","title":"Abscisic Acid Effects on Glucose Homeostasis and Insulin Sensitivity","status":"COMPLETED","sponsor":"AdventHealth Translational Research Institute","startDate":"2021-03-08","conditions":"Pre Diabetes","enrollment":5},{"nctId":"NCT05799781","phase":"NA","title":"Two Way Crossover Closed Loop MPC vs Control IQ","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2023-03-13","conditions":"Type 1 Diabetes","enrollment":29},{"nctId":"NCT06422325","phase":"NA","title":"Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2024-07-12","conditions":"Type 1 Diabetes","enrollment":33},{"nctId":"NCT07325461","phase":"NA","title":"Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes","status":"RECRUITING","sponsor":"Tandem Diabetes Care, Inc.","startDate":"2026-02-18","conditions":"Diabetes Mellitus, Type 1","enrollment":20},{"nctId":"NCT07451561","phase":"NA","title":"Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03","conditions":"Acute Aluminum Phosphide Poisoned Cases","enrollment":74},{"nctId":"NCT05985135","phase":"NA","title":"Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-06-01","conditions":"Type 1 Diabetes","enrollment":70},{"nctId":"NCT07348809","phase":"NA","title":"The Effects Of Virtual Reality and Stress Ball Application on Pain, Anxiety Levels and Injection Satisfaction in During Insulin Injection in Geriatric Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tarsus University","startDate":"2024-11-01","conditions":"Diabete Type 2, Virtual Reality, Stress Ball","enrollment":90},{"nctId":"NCT06449677","phase":"PHASE3","title":"Bionic Pancreas in CFRD","status":"RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2024-09-24","conditions":"Cystic Fibrosis-related Diabetes","enrollment":150},{"nctId":"NCT06624956","phase":"PHASE4","title":"Prevention and Treatment of Common Hyperglycemia in Surgery Pilot","status":"COMPLETED","sponsor":"University of Washington","startDate":"2024-09-04","conditions":"Surgery, Non Diabetic Hyperglycemia","enrollment":106},{"nctId":"NCT07423559","phase":"NA","title":"Relapse Among Diabetic Ketoacidosis Patients Maintained Basal Bolus Insulin Administration in Combination With Continuous Intravenous Insulin Infusion VS Non Maintaining Basal Insulin Patients","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-11-30","conditions":"Diabetic Ketoacidosis, Insulin, Intensive Care Unit Stay","enrollment":100},{"nctId":"NCT06369649","phase":"NA","title":"Coolsense and Buzzy Use on Pain Score and Anxiety Level During Insulin Injection Application","status":"COMPLETED","sponsor":"Ankara Yildirim Beyazıt University","startDate":"2023-07-01","conditions":"Injection Fear, Injection Site Coldness, Pain","enrollment":90},{"nctId":"NCT07420972","phase":"NA","title":"Pilot Study of Intrapartum Insulin Pump","status":"NOT_YET_RECRUITING","sponsor":"Medstar Health Research Institute","startDate":"2026-04","conditions":"Diabetes, Diabetes (Insulin-requiring, Type 1 or Type 2), Pregnancy","enrollment":30},{"nctId":"NCT06111586","phase":"PHASE2","title":"FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2023-12-11","conditions":"Type 1 Diabetes Mellitus","enrollment":192},{"nctId":"NCT07059091","phase":"PHASE2","title":"Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-02-12","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Allergies","enrollment":334},{"nctId":"NCT06295640","phase":"NA","title":"Relative Contribution of Brain Insulin Action for Postprandial Metabolism","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Ulm","startDate":"2024-03-18","conditions":"Glucose Metabolism Disorders","enrollment":31},{"nctId":"NCT06470295","phase":"EARLY_PHASE1","title":"Effect of C-peptide on Hypoglycemic Counterregulation","status":"RECRUITING","sponsor":"University of Cincinnati","startDate":"2024-06-01","conditions":"Hypoglycemia, Type 1 Diabetes","enrollment":38},{"nctId":"NCT03479671","phase":"EARLY_PHASE1","title":"Low Dose Fat-Induced Insulin Resistance","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-01-01","conditions":"Diabetes Mellitus, Type 2, Insulin Resistance, Insulin Sensitivity","enrollment":9},{"nctId":"NCT06782568","phase":"NA","title":"Avoidance of Insulin-induced Lipohypertophy in People With Diabetes Using Ultrasound Scanning Within Diabetes Clinics","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2026-01-01","conditions":"Type 1 Diabetes (T1D), Type 2 Diabetes, Insulin Requiring","enrollment":50},{"nctId":"NCT06330194","phase":"NA","title":"Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal Disease","status":"COMPLETED","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2024-04-18","conditions":"Dialysis, Chronic Kidney Disease, Diabetes Mellitus, Type 2","enrollment":15},{"nctId":"NCT07167693","phase":"PHASE1, PHASE2","title":"Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes","status":"RECRUITING","sponsor":"David K Carroll","startDate":"2025-12-19","conditions":"Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes","enrollment":60},{"nctId":"NCT07407881","phase":"NA","title":"Shot Blocker and Manual Pressure Application","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mansoura University","startDate":"2025-07-25","conditions":"Injection Pain Prevention","enrollment":108},{"nctId":"NCT07403604","phase":"PHASE1","title":"Effect of Insulin Lowering on Lipogenesis","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-04","conditions":"Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease","enrollment":25},{"nctId":"NCT07398300","phase":"NA","title":"Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2026-03-12","conditions":"Type 2 Diabetes, Healhty","enrollment":36},{"nctId":"NCT06558422","phase":"PHASE1","title":"Human Models of Selective Insulin Resistance: Pancreatic Clamp","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2027-01-01","conditions":"Insulin Resistance, Hyperinsulinemia, Metabolic Dysfunction Associated Steatotic Liver Disease","enrollment":36},{"nctId":"NCT06883344","phase":"NA","title":"Automated Insulin for Management of Intrapartum Glycemia","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-12-05","conditions":"Type 1 Diabetes (T1D), Pregnancy, Pre-Gestational Diabetes","enrollment":150},{"nctId":"NCT07224334","phase":"PHASE1","title":"Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.","status":"RECRUITING","sponsor":"David D'Alessio, M.D.","startDate":"2025-12-30","conditions":"Diabetes (DM)","enrollment":30},{"nctId":"NCT07261475","phase":"EARLY_PHASE1","title":"Crocus Sativus Tepals Water Extract in Obesity and Prediabetes","status":"RECRUITING","sponsor":"University of Primorska","startDate":"2026-02-06","conditions":"Prediabetes, Obesity & Overweight","enrollment":20},{"nctId":"NCT07246421","phase":"NA","title":"Glucagon Resistance in Patients With MASLD and T2DM","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2026-01-29","conditions":"Metabolic Associated Fatty Liver Disease, Type 2 Diabetes (T2DM)","enrollment":24},{"nctId":"NCT07375875","phase":"NA","title":"Strategies to Minimize the Risk for Insulin Induced Hypertrophy and Its Related Consequences","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2025-05-15","conditions":"Insulin Dependent Diabetes Mellitus","enrollment":170},{"nctId":"NCT07376200","phase":"PHASE1","title":"Single-ascending Dose Study of HEC-151 Injection","status":"NOT_YET_RECRUITING","sponsor":"Sunshine Lake Pharma Co., Ltd.","startDate":"2026-03-11","conditions":"Healthy Adult Male","enrollment":81},{"nctId":"NCT04614168","phase":"NA","title":"Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2021-07-26","conditions":"Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia, Hypoglycemia","enrollment":24},{"nctId":"NCT06722560","phase":"NA","title":"SHORT-term Effects of GLucagon-like Peptide One on BonE","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2025-01-07","conditions":"To Investigate the Physiological Effect of GLP-1 on the Skeleton, Healthy Volunteer","enrollment":12},{"nctId":"NCT07088497","phase":"","title":"Cmate Blood Glucose Analyzer: Clinical Comparison Study of Fasting Blood Glucose Levels in the Morning","status":"COMPLETED","sponsor":"Revlis Biotech Company Limited","startDate":"2025-07-21","conditions":"Glucose, Diabetes","enrollment":40},{"nctId":"NCT07061301","phase":"NA","title":"Transition to Hospital Discharge in Insulinized Patients With Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2024-08-01","conditions":"Type 2 Diabetes Mellitus (T2DM), Continuous Glucose Monitoring, CGM","enrollment":80},{"nctId":"NCT07359625","phase":"NA","title":"Effects of Ketone Bodies on Insulin Sensitivity","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2025-12-02","conditions":"Insulin Resistance, Obesity & Overweight, Energy Metabolism","enrollment":10},{"nctId":"NCT05669547","phase":"NA","title":"Dual Hormone Closed Loop in Type 1 Diabetes","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2023-10-03","conditions":"Diabetes Mellitus, Type 1, Diabetes type1, Diabetes","enrollment":243},{"nctId":"NCT05724134","phase":"PHASE1","title":"Pancreatic Clamp in NAFLD","status":"COMPLETED","sponsor":"Columbia University","startDate":"2023-08-29","conditions":"Insulin Resistance, Prediabetic State, Hyperinsulinemia","enrollment":18},{"nctId":"NCT03818178","phase":"NA","title":"Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-12-01","conditions":"Insulin Resistance","enrollment":60},{"nctId":"NCT07326865","phase":"NA","title":"Hepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric Surgery","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-11-12","conditions":"MASLD","enrollment":40},{"nctId":"NCT03746431","phase":"PHASE1","title":"A Phase 1 Study of [225Ac]-FPI-1434 Injection","status":"TERMINATED","sponsor":"Fusion Pharmaceuticals Inc.","startDate":"2019-01-17","conditions":"Advanced Solid Tumours, Endometrial Cancer, Cervical Cancer","enrollment":78},{"nctId":"NCT03253263","phase":"PHASE2","title":"A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants","status":"RECRUITING","sponsor":"OHB Neonatology Ltd.","startDate":"2019-05-09","conditions":"Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage","enrollment":338},{"nctId":"NCT06463028","phase":"PHASE2","title":"Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer","status":"RECRUITING","sponsor":"Faeth Therapeutics","startDate":"2024-12-12","conditions":"Endometrial Cancer","enrollment":40},{"nctId":"NCT07300982","phase":"PHASE1, PHASE2","title":"Studies of Insulin and Glucagon Action in the Liver","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-04","conditions":"Diabetes (DM)","enrollment":40},{"nctId":"NCT06609356","phase":"EARLY_PHASE1","title":"Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2025-07-03","conditions":"Type 1 Diabetes Mellitus, Glucokinase-Maturity Onset Diabetes of the Young (GCK-MODY), MODY2 Diabetes","enrollment":27},{"nctId":"NCT06643351","phase":"NA","title":"Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2024-12-03","conditions":"Gestational Diabetes Mellitus in Pregnancy, Pregestational Diabetes Mellitus, Neonatal Hypoglycemia","enrollment":218},{"nctId":"NCT02724566","phase":"PHASE1","title":"Effect of Apelin on Insulin Sensitivity in Type 2 Diabetic Volunteers","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2016-05","conditions":"Diabetes","enrollment":9},{"nctId":"NCT06552130","phase":"NA","title":"The Importance of Insulin Action in the Brain for the Immune System During Physical Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Ulm","startDate":"2024-12-15","conditions":"Insulin Sensitivity","enrollment":20},{"nctId":"NCT06592261","phase":"PHASE1","title":"Graded Insulin Suppression Test P&F","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-09-16","conditions":"Insulin Resistance, Hyperinsulinemia, Obesity","enrollment":15},{"nctId":"NCT06354088","phase":"PHASE1","title":"Human Models of Selective Insulin Resistance: Alpelisib, Part I","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-04-24","conditions":"Insulin Resistance, Prediabetic State, Overweight and Obesity","enrollment":32},{"nctId":"NCT07090824","phase":"PHASE1","title":"Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes","status":"RECRUITING","sponsor":"Stanford University","startDate":"2025-10-28","conditions":"Diabetes Mellitus, Type 1, Type 1 Diabetes Mellitus","enrollment":20},{"nctId":"NCT07265323","phase":"NA","title":"Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition","status":"RECRUITING","sponsor":"Pennington Biomedical Research Center","startDate":"2025-12","conditions":"Alzheimer s Disease, Alzheimer Blood Biomarkers, Insulin Sensitivity","enrollment":8},{"nctId":"NCT07052292","phase":"","title":"User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2025-07-01","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":125},{"nctId":"NCT02546401","phase":"PHASE3","title":"Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2015-09","conditions":"Diabetes Type 1","enrollment":22},{"nctId":"NCT05013229","phase":"PHASE3","title":"A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-11-30","conditions":"Diabetes Mellitus, Type 2","enrollment":679},{"nctId":"NCT06776094","phase":"NA","title":"Physical Activity and Insulin Sensitivity Dynamics","status":"RECRUITING","sponsor":"University of Copenhagen","startDate":"2025-05-05","conditions":"Insulin Sensitivity","enrollment":8},{"nctId":"NCT07252752","phase":"NA","title":"Dopamine and Insulin in Psychosis","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Vienna","startDate":"2026-01-01","conditions":"First Episode Psychosis (FEP)","enrollment":46},{"nctId":"NCT07241702","phase":"","title":"EFFECT OF HYBRID CLOSED-LOOP SYSTEMS ON CARDIOVASCULAR MARKERS IN TYPE 1 DIABETES.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Attikon Hospital","startDate":"2019-09-01","conditions":"Type 1 Diabetes","enrollment":100},{"nctId":"NCT05389514","phase":"","title":"Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Providence Health & Services","startDate":"","conditions":"KRAS G12V Mutant Advanced Epithelial Cancers","enrollment":""},{"nctId":"NCT07237841","phase":"NA","title":"Preoperative Carbohydrate Loading in Diabetes Mellitus","status":"COMPLETED","sponsor":"Gia Dinh People Hospital","startDate":"2023-03-01","conditions":"Type2diabetes, Enhanced Recovery After Surgery (ERAS), Fasting","enrollment":76},{"nctId":"NCT07239700","phase":"NA","title":"Buzzy and TickleFlex in Reducing Insulin Injection Pain and Fear","status":"ENROLLING_BY_INVITATION","sponsor":"Hakkari Universitesi","startDate":"2025-06-06","conditions":"Diabete Type 1, Diabetes in Children","enrollment":90},{"nctId":"NCT06418880","phase":"PHASE3","title":"Automated Insulin Delivery for Inpatients With Dysglycemia","status":"COMPLETED","sponsor":"Emory University","startDate":"2025-01-22","conditions":"Type 1 Diabetes, Type 2 Diabetes","enrollment":130},{"nctId":"NCT01909245","phase":"PHASE2","title":"Islet Cell Transplant for Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2013-10-16","conditions":"Type 1 Diabetes Mellitus","enrollment":10},{"nctId":"NCT04443153","phase":"NA","title":"Adapting Diabetes Treatment Expert Systems to Patient in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2020-09-04","conditions":"Diabetes Mellitus, Type 1","enrollment":88},{"nctId":"NCT07187479","phase":"NA","title":"Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"Well Cell Global","startDate":"2025-10-14","conditions":"Chronic Kidney Disease (Stages 4 and 5), Kidney Disease, Type 2 Diabetes","enrollment":120},{"nctId":"NCT06090864","phase":"PHASE1, PHASE2","title":"ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells","status":"RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2024-04-25","conditions":"Hodgkin Lymphoma, Relapse, Refractory","enrollment":31},{"nctId":"NCT06548100","phase":"PHASE3","title":"A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2024-12-16","conditions":"Generalized Lipodystrophy","enrollment":9},{"nctId":"NCT07207694","phase":"NA","title":"WhatsApp-Based Education Program for Stroke Patients","status":"NOT_YET_RECRUITING","sponsor":"Gaziler Physical Medicine and Rehabilitation Education and Research Hospital","startDate":"2025-10-15","conditions":"Type 2 Diabetes Mellitus (T2DM), Stroke","enrollment":84},{"nctId":"NCT06923839","phase":"PHASE1","title":"Testing the Potential Metabolic Effect of the Human Gut Bacterial Peptide, RUCILP, in Healthy Men","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oluf Pedersen","startDate":"2025-07-28","conditions":"Healthy Male Adults","enrollment":15},{"nctId":"NCT06461065","phase":"NA","title":"Evaluation of Neurodevelopmental Trajectories in Children According to the Glycemic Profile Associated With Different Early Treatment Modalities in Children With Type 1 Diabetes (T1DM)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-02-20","conditions":"Diabetes","enrollment":60},{"nctId":"NCT07194642","phase":"NA","title":"Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Non-ICU Patients Receiving Corticosteroid Therapy and Specialized Nutrition","status":"NOT_YET_RECRUITING","sponsor":"University of Nebraska","startDate":"2025-09-30","conditions":"Diabetes","enrollment":80},{"nctId":"NCT06424015","phase":"NA","title":"Insulin and Insulin Pulses During Fasting","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-09-15","conditions":"PreDiabetes","enrollment":60},{"nctId":"NCT04233138","phase":"NA","title":"SUPPORT Online Training Platform for Type 1 Diabetes Self-management Education and Support (SUPPORT)","status":"COMPLETED","sponsor":"McGill University","startDate":"2020-02-05","conditions":"Type 1 Diabetes Mellitus With Hypoglycemia","enrollment":285},{"nctId":"NCT01471808","phase":"PHASE4","title":"Effects of Different Early Intensive Therapies on Long-term β-cell Function","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2011-10","conditions":"Diabetes Mellitus, Type 2","enrollment":264},{"nctId":"NCT06273124","phase":"NA","title":"Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes","status":"COMPLETED","sponsor":"Tandem Diabetes Care, Inc.","startDate":"2024-03-07","conditions":"Type1diabetes","enrollment":260},{"nctId":"NCT07117240","phase":"PHASE4","title":"Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes","status":"ENROLLING_BY_INVITATION","sponsor":"Medical University of Warsaw","startDate":"2025-07-10","conditions":"Steroid-Induced Diabetes, Steroid-Induced Hyperglycemia, Diabetes","enrollment":100},{"nctId":"NCT02994277","phase":"NA","title":"Artificial Pancreas in Latin America","status":"COMPLETED","sponsor":"Hospital Italiano de Buenos Aires","startDate":"2016-11","conditions":"Diabetes","enrollment":5},{"nctId":"NCT01648478","phase":"NA","title":"IRAPs (Secreted Insulin Regulated AminoPeptidase): a New Insulin Sensitivity Biomarker","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2012-06","conditions":"Insulin Resistance","enrollment":21},{"nctId":"NCT03608163","phase":"PHASE4","title":"Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)","status":"TERMINATED","sponsor":"Albert Einstein College of Medicine","startDate":"2019-01-08","conditions":"Diabetes Mellitus, Type 1, Hypoglycemia, Hypoglycemia Unawareness","enrollment":4},{"nctId":"NCT07165327","phase":"NA","title":"Injection Ports vs Single-Use Needles for Insulin in Pregnancy: Effects on Adherence and Satisfaction","status":"NOT_YET_RECRUITING","sponsor":"University of Texas at Austin","startDate":"2025-10","conditions":"Gestatiaonl Diabetes Mellitus, Pregnancy, Diabetes in Pregnancy","enrollment":44},{"nctId":"NCT06256614","phase":"","title":"Washed Microbiota Transplantation for Type 1 Diabetes Mellitus","status":"RECRUITING","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2024-03-01","conditions":"Type 1 Diabetes","enrollment":50},{"nctId":"NCT01803451","phase":"EARLY_PHASE1","title":"Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2005-11","conditions":"Post-bariatric Surgery","enrollment":80},{"nctId":"NCT05528770","phase":"NA","title":"Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery","status":"COMPLETED","sponsor":"Marc Breton","startDate":"2022-10-20","conditions":"Type 1 Diabetes","enrollment":15},{"nctId":"NCT07068295","phase":"PHASE1","title":"A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin Pump","status":"RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2025-07-11","conditions":"Diabetes Mellitus, Type 2","enrollment":65},{"nctId":"NCT05299177","phase":"NA","title":"Feasibility of Automated Insulin Delivery With an Interoperable Algorithm Using an Alternative Insulin Pump","status":"TERMINATED","sponsor":"Imperial College London","startDate":"2022-04-01","conditions":"Type 1 Diabetes","enrollment":1},{"nctId":"NCT04066959","phase":"NA","title":"Improving Diabetes in Emerging Adulthood","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2020-11-16","conditions":"Diabetes Mellitus, Type 1","enrollment":113},{"nctId":"NCT06809621","phase":"PHASE1","title":"A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 1 Diabetes When Given by an Insulin Pump","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2025-01-29","conditions":"Diabetes Mellitus, Type 1","enrollment":43},{"nctId":"NCT01493934","phase":"PHASE1, PHASE2","title":"Development of a Fast Measurement Technique of Insulin Resistance in Human","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2010-04","conditions":"Type 2 Diabetes Mellitus","enrollment":12},{"nctId":"NCT07133854","phase":"NA","title":"How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver","status":"NOT_YET_RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2026-09","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-Alcoholic Steato-Hepatitis (NASH), Type 1 Diabetes Mellitus","enrollment":32},{"nctId":"NCT02748018","phase":"NA","title":"Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home","status":"COMPLETED","sponsor":"Medtronic Diabetes","startDate":"2017-05-25","conditions":"Type 1 Diabetes","enrollment":959}],"_emaApprovals":[],"_faersSignals":[{"count":4,"reaction":"NAUSEA"},{"count":3,"reaction":"DEHYDRATION"},{"count":3,"reaction":"DIABETIC KETOACIDOSIS"},{"count":3,"reaction":"VOMITING"},{"count":2,"reaction":"BEZOAR"},{"count":2,"reaction":"BLOOD CREATININE INCREASED"},{"count":2,"reaction":"CARDIAC ARREST"},{"count":2,"reaction":"DEVICE FAILURE"},{"count":2,"reaction":"PLASMA CELL MYELOMA"},{"count":2,"reaction":"PYREXIA"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["insuman rapid","Intravenous regular insulin infusion"],"phase":"marketed","status":"active","brandName":"insulin infusion","genericName":"insulin infusion","companyName":"IKFE Institute for Clinical Research and Development","companyId":"ikfe-institute-for-clinical-research-and-development","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Insulin infusion delivers exogenous insulin directly into the bloodstream to regulate blood glucose by promoting cellular glucose uptake and storage. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus (when oral agents are insufficient), Acute hyperglycemia in hospitalized patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}